Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
NEW YORK — Four New York shops have advanced in TAP Pharmaceutical Products’$100 million Prevacid review: McCann-Erickson, Ogilvy & Mather, Deutsch and Merkley Newman Harty & Partners, sources said.
Two other New York shops that responded to TAP’s RFP–TBWA\Chiat\Day and Young & Rubicam–were eliminated last week, said sources.
Last Thursday and Friday, client executives briefed the four finalists in preparation for final pitches, which are scheduled for mid-September, according to sources. The briefings took place at the agencies, each one lasting up to three hours.
The
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in